Similarly, hemochromatosis patients with HCC had higher rates of p53 mutations than other HCC patients [56], indicating the involvement of an important tumor suppressor gene, p53, in iron-mediated tumor progression. The gene discussed is TP53; the disease is hepatocellular carcinoma.